Cargando…
Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
OBJECTIVE: To verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels. DESIGN: Retrospective cohort study. SETTING: University-based hospital....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314175/ https://www.ncbi.nlm.nih.gov/pubmed/34326810 http://dx.doi.org/10.3389/fendo.2021.618580 |
_version_ | 1783729493917040640 |
---|---|
author | Liu, Shan Liu, Minghui Li, Lingxiu Li, Huanhuan Qu, Danni Ren, Haiying Su, Hui Zhang, Yang Li, Yuan |
author_facet | Liu, Shan Liu, Minghui Li, Lingxiu Li, Huanhuan Qu, Danni Ren, Haiying Su, Hui Zhang, Yang Li, Yuan |
author_sort | Liu, Shan |
collection | PubMed |
description | OBJECTIVE: To verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels. DESIGN: Retrospective cohort study. SETTING: University-based hospital. PATIENTS: 110 patients exhibited ultra-low LH levels during ovarian stimulation using GnRH agonist long protocol. INTERVENTION(S): As all the embryos in the first cycle were exhausted without being pregnant, these patients proposed to undergo a second cycle of ovarian stimulation. 74 of them were treated with a modified GnRH antagonist protocol based on LH levels. Other 36 patients were still stimulated following GnRH agonist long protocol. MAIN OUTCOME MEASURE: The primary outcome was live birth rate (LBR). The second outcomes were biochemical pregnancy rate, clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR) and cancellation rate. RESULTS: Reproductive outcomes were much better in the modified GnRH antagonist protocol. The OPR and LBR were much higher in the GnRH antagonist protocol group than in the GnRH agonist long protocol group [odds ratio (OR) 3.82, 95% confidence interval (CI) 1.47, 10.61, P=0.018; OR 4.33, 95% CI 1.38, 13.60, P=0.008; respectively]. Meanwhile, the cancellation rate was much lower in the GnRH antagonist protocol group (OR 0.13, 95% CI 0.02, 0.72; P=0.014). Mean LH level during stimulation did not have a predictive value on live birth. However, it was independently associated with the occurrence of ongoing pregnancy (OR 2.70, 95% CI 1.25, 5.85; P=0.01). The results of sensitivity analyses were consistent with the data mentioned above. The patients got completely different and excellent clinical outcomes in their second cycles stimulated with the modified GnRH antagonist protocol. CONCLUSION: Patients with deep ovarian suppression following GnRH agonist long protocol may benefit from a modified GnRH antagonist protocol based on LH levels. |
format | Online Article Text |
id | pubmed-8314175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83141752021-07-28 Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study Liu, Shan Liu, Minghui Li, Lingxiu Li, Huanhuan Qu, Danni Ren, Haiying Su, Hui Zhang, Yang Li, Yuan Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: To verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels. DESIGN: Retrospective cohort study. SETTING: University-based hospital. PATIENTS: 110 patients exhibited ultra-low LH levels during ovarian stimulation using GnRH agonist long protocol. INTERVENTION(S): As all the embryos in the first cycle were exhausted without being pregnant, these patients proposed to undergo a second cycle of ovarian stimulation. 74 of them were treated with a modified GnRH antagonist protocol based on LH levels. Other 36 patients were still stimulated following GnRH agonist long protocol. MAIN OUTCOME MEASURE: The primary outcome was live birth rate (LBR). The second outcomes were biochemical pregnancy rate, clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR) and cancellation rate. RESULTS: Reproductive outcomes were much better in the modified GnRH antagonist protocol. The OPR and LBR were much higher in the GnRH antagonist protocol group than in the GnRH agonist long protocol group [odds ratio (OR) 3.82, 95% confidence interval (CI) 1.47, 10.61, P=0.018; OR 4.33, 95% CI 1.38, 13.60, P=0.008; respectively]. Meanwhile, the cancellation rate was much lower in the GnRH antagonist protocol group (OR 0.13, 95% CI 0.02, 0.72; P=0.014). Mean LH level during stimulation did not have a predictive value on live birth. However, it was independently associated with the occurrence of ongoing pregnancy (OR 2.70, 95% CI 1.25, 5.85; P=0.01). The results of sensitivity analyses were consistent with the data mentioned above. The patients got completely different and excellent clinical outcomes in their second cycles stimulated with the modified GnRH antagonist protocol. CONCLUSION: Patients with deep ovarian suppression following GnRH agonist long protocol may benefit from a modified GnRH antagonist protocol based on LH levels. Frontiers Media S.A. 2021-07-13 /pmc/articles/PMC8314175/ /pubmed/34326810 http://dx.doi.org/10.3389/fendo.2021.618580 Text en Copyright © 2021 Liu, Liu, Li, Li, Qu, Ren, Su, Zhang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Liu, Shan Liu, Minghui Li, Lingxiu Li, Huanhuan Qu, Danni Ren, Haiying Su, Hui Zhang, Yang Li, Yuan Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study |
title | Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study |
title_full | Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study |
title_fullStr | Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study |
title_full_unstemmed | Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study |
title_short | Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study |
title_sort | patients with deep ovarian suppression following gnrh agonist long protocol may benefit from a modified gnrh antagonist protocol: a retrospective cohort study |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314175/ https://www.ncbi.nlm.nih.gov/pubmed/34326810 http://dx.doi.org/10.3389/fendo.2021.618580 |
work_keys_str_mv | AT liushan patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT liuminghui patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT lilingxiu patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT lihuanhuan patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT qudanni patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT renhaiying patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT suhui patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT zhangyang patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy AT liyuan patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy |